Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Neurocrine Biosciences (NBIX) Debt Ratio (2018 - 2024)

Neurocrine Biosciences (NBIX) has disclosed Debt Ratio for 4 consecutive years, with 0.04 as the latest value for Q1 2024.

  • For the quarter ending Q1 2024, Debt Ratio changed N/A year-over-year to 0.04, compared with a TTM value of 0.04 through Mar 2024, changed N/A, and an annual FY2023 reading of 0.05, changed N/A over the prior year.
  • Debt Ratio was 0.04 for Q1 2024 at Neurocrine Biosciences, down from 0.05 in the prior quarter.
  • Across five years, Debt Ratio topped out at 0.28 in Q3 2020 and bottomed at 0.04 in Q1 2024.
  • Average Debt Ratio over 3 years is 0.13, with a median of 0.06 recorded in 2023.